California Nanotechnologies Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA1304921010
CAD
0.27
-0.03 (-11.48%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company has declared negative results in Nov 24 after 5 consecutive negative quarters

  • NET SALES(HY) At CAD 1.62 MM has Grown at -64.58%
  • OPERATING CASH FLOW(Y) Lowest at CAD 0.02 MM
  • ROCE(HY) Lowest at -110.37%
2

Risky -

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 15 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

-120.99%

stock-summary
Price to Book

4.90

Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Nov 2025)
Net Profit:
-2 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.9%
0%
-12.9%
6 Months
-18.18%
0%
-18.18%
1 Year
-61.97%
0%
-61.97%
2 Years
-29.87%
0%
-29.87%
3 Years
145.45%
0%
145.45%
4 Years
237.5%
0%
237.5%
5 Years
157.14%
0%
157.14%

California Nanotechnologies Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
31.16%
EBIT Growth (5y)
-211.20%
EBIT to Interest (avg)
0.62
Debt to EBITDA (avg)
1.05
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
2.30
Tax Ratio
24.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
39.85%
ROE (avg)
25.88%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.90
EV to EBIT
-5.18
EV to EBITDA
-8.05
EV to Capital Employed
4.95
EV to Sales
3.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-95.41%
ROE (Latest)
-120.99%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is -54.55% vs 10.00% in Aug 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Nov 2025 is -275.00% vs 33.33% in Aug 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Aug'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.50",
          "val2": "1.10",
          "chgp": "-54.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.90",
          "val2": "-0.20",
          "chgp": "-350.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.50",
          "val2": "-0.40",
          "chgp": "-275.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,105.40%",
          "val2": "-450.60%",
          "chgp": "-165.48%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Feb'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Feb 2025 is 91.11% vs 150.00% in Feb 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Feb 2025 is -140.00% vs 400.00% in Feb 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Feb'25",
        "Feb'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.60",
          "val2": "4.50",
          "chgp": "91.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.70",
          "val2": "1.10",
          "chgp": "145.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.10",
          "chgp": "200.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.70",
          "val2": "-0.20",
          "chgp": "-750.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "0.50",
          "chgp": "-140.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "222.00%",
          "val2": "190.30%",
          "chgp": "3.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Nov'25 - QoQstock-summary

Nov'25
Aug'25
Change(%)
Net Sales
0.50
1.10
-54.55%
Operating Profit (PBDIT) excl Other Income
-0.90
-0.20
-350.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.20
-100.00%
Consolidate Net Profit
-1.50
-0.40
-275.00%
Operating Profit Margin (Excl OI)
-2,105.40%
-450.60%
-165.48%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Nov 2025 is -54.55% vs 10.00% in Aug 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Nov 2025 is -275.00% vs 33.33% in Aug 2025

Annual Results Snapshot (Consolidated) - Feb'25stock-summary

Feb'25
Feb'24
Change(%)
Net Sales
8.60
4.50
91.11%
Operating Profit (PBDIT) excl Other Income
2.70
1.10
145.45%
Interest
0.30
0.10
200.00%
Exceptional Items
-1.70
-0.20
-750.00%
Consolidate Net Profit
-0.20
0.50
-140.00%
Operating Profit Margin (Excl OI)
222.00%
190.30%
3.17%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Feb 2025 is 91.11% vs 150.00% in Feb 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Feb 2025 is -140.00% vs 400.00% in Feb 2024

stock-summaryCompany CV
About California Nanotechnologies Corp. stock-summary
stock-summary
California Nanotechnologies Corp.
Pharmaceuticals & Biotechnology
California Nanotechnologies Corp. is engaged in the development of nanocrystalline materials through grain size reduction. The Company focuses on commercialization efforts. It targets various markets, such as consumer electronics, aerospace, defense, automotive, oil and gas, medical, and sports and recreation. It supplies thermal spray powders that are utilized for wear, corrosion and thermal barrier coatings. Powders are available for plasma, high velocity oxygen fuel (HVOF) and particle tracking analysis (PTA) welding. Its Spark Plasma Sintering (SPS) allows for the application of temperature and pressure through high-density pulsed current within a controlled atmosphere. SPS applications include semiconductors, fine ceramics, thermoelectrics, electronics, nanophases, hard alloy tools, biomaterials, porous materials and molds and dies. To provide its products, the Company has an array of production facilities, including cold forging, cryogenic milling and spray drying.
Company Coordinates stock-summary
Company Details
17220 Edwards Rd , CERRITOS CA : 90703-2426
stock-summary
Tel: 1 562 9915211
stock-summary
Registrar Details